Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
Praxis Precision Medicines
company
About
Praxis Precision Medicines offers drug development services.
- 51 - 100
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $110M
- Industries
- Alternative Medicine,Biotechnology,Health Care,Medical
- Founded date
- Sep 22, 2015
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders (CNS) characterized by neuronal imbalance. Praxis is applying insights from genetic epilepsies to broader neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$110M
Praxis Precision Medicines has raised a total of
$110M
in funding over 2 rounds. Their latest funding was raised on
Jul 28, 2020 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jul 28, 2020 | Series C | $110M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Praxis Precision Medicines is funded by 1 investors.
Ample Plus Fund
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
